{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:59:53Z","timestamp":1791453593550,"version":"4.3.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s13555-025-01576-y","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:46:36Z","timestamp":1761882396000},"page":"323-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Psychiatric Burden in Alopecia Areata: A Propensity-Matched Cohort Study"],"prefix":"10.1007","volume":"16","author":[{"given":"Katarzyna","family":"\u0141uczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"S\u00f3jka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Saceda","family":"Corralo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-6342","authenticated-orcid":false,"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr K.","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"1576_CR1","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2014.530","volume":"135","author":"FJ Dalgard","year":"2015","unstructured":"Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135:984\u201391.","journal-title":"J Invest Dermatol"},{"key":"1576_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1046\/j.1365-2133.2000.03831.x","volume":"143","author":"A Picardi","year":"2000","unstructured":"Picardi A, Abeni D, Melchi CF, Puddu P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. 2000;143:983\u201391.","journal-title":"Br J Dermatol"},{"key":"1576_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5114\/ada.2022.119080","volume":"40","author":"JE Rymaszewska","year":"2023","unstructured":"Rymaszewska JE, Krajewski PK, Szczech J, Szepietowski JC. Depression and anxiety in hidradenitis suppurativa patients: a cross-sectional study among Polish patients. Postepy Dermatol Alergol. 2023;40:35\u20139.","journal-title":"Postepy Dermatol Alergol"},{"key":"1576_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175741","author":"A Zalewski","year":"2023","unstructured":"Zalewski A, Krajewski PK, Szepietowski JC. Psychosocial consequences of hand eczema-a prospective cross-sectional study. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12175741.","journal-title":"J Clin Med"},{"key":"1576_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","volume":"62","author":"A Alkhalifah","year":"2010","unstructured":"Alkhalifah A, Alsantali A, Wang E, McElwee KJ. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62:177\u201388.","journal-title":"J Am Acad Dermatol"},{"key":"1576_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2133.2011.10714.x","volume":"166","author":"SY Chu","year":"2012","unstructured":"Chu SY, Chen YJ, Tseng WC, Lin MW. Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol. 2012;166:525\u201331.","journal-title":"Br J Dermatol"},{"key":"1576_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3671","volume":"341","author":"MJ Harries","year":"2010","unstructured":"Harries MJ, Sun J, Paus R, King LE Jr. Management of alopecia areata. BMJ. 2010;341:c3671.","journal-title":"BMJ"},{"key":"1576_CR8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/jid.2013.464","volume":"134","author":"SA Mirzoyev","year":"2014","unstructured":"Mirzoyev SA, Schrum AG, Davis MDP. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990\u20132009. J Invest Dermatol. 2014;134:1141\u20132 (Torgerson RR).","journal-title":"J Invest Dermatol"},{"key":"1576_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","volume":"149","author":"KP Huang","year":"2013","unstructured":"Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149:789\u201394.","journal-title":"JAMA Dermatol"},{"key":"1576_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/0974-7753.136746","volume":"6","author":"A Ghanizadeh","year":"2014","unstructured":"Ghanizadeh A, Ayoobzadehshirazi A. A review of psychiatric disorders comorbidities in patients with alopecia areata. Int J Trichology. 2014;6:2\u20134.","journal-title":"Int J Trichology"},{"key":"1576_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.1365-4362.1994.tb01018.x","volume":"33","author":"JY Koo","year":"1994","unstructured":"Koo JY, Shellow WV, Hallman CP. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol. 1994;33:849\u201350 (Edwards JE).","journal-title":"Int J Dermatol"},{"key":"1576_CR12","doi-asserted-by":"publisher","first-page":"1516126","DOI":"10.3389\/fphar.2025.1516126","volume":"16","author":"RJ Ludwig","year":"2025","unstructured":"Ludwig RJ, Anson M, Zirpel H, Thaci D. A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX. Front Pharmacol. 2025;16:1516126.","journal-title":"Front Pharmacol"},{"key":"1576_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000497166","volume":"5","author":"RDC V\u00e9lez-Mu\u00f1iz","year":"2019","unstructured":"V\u00e9lez-Mu\u00f1iz RDC, Peralta-Pedrero ML, Jurado-Santa Cruz F, Morales-S\u00e1nchez MA. Psychological profile and quality of life of patients with alopecia areata. Skin Appendage Disord. 2019;5:293\u20138.","journal-title":"Skin Appendage Disord"},{"key":"1576_CR14","first-page":"891","volume":"146","author":"SK Kurd","year":"2010","unstructured":"Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:891\u20135.","journal-title":"Arch Dermatol"},{"key":"1576_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00403-025-04181-3","volume":"317","author":"AA Abdel-Azim","year":"2025","unstructured":"Abdel-Azim AA, Ismail RM, Ahmed Elshabasy HS, Pessar DAH. Psychiatric disorders in psoriatic patients: a cross-sectional study in multi-government hospitals. Arch Dermatol Res. 2025;317:722.","journal-title":"Arch Dermatol Res"},{"key":"1576_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/jpgm.JPGM_253_18","volume":"65","author":"P Ungprasert","year":"2019","unstructured":"Ungprasert P, Wijarnpreecha K, Cheungpasitporn W. Patients with psoriasis have a higher risk of schizophrenia: a systematic review and meta-analysis of observational studies. J Postgrad Med. 2019;65:141\u20135.","journal-title":"J Postgrad Med"},{"key":"1576_CR17","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.1038\/s41598-024-59162-9","volume":"14","author":"SP Hartono","year":"2024","unstructured":"Hartono SP, Chatrath S, Aktas ON, Kubala SA. Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis. Sci Rep. 2024;14:8844.","journal-title":"Sci Rep"},{"key":"1576_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jad.2015.02.025","volume":"178","author":"CM Cheng","year":"2015","unstructured":"Cheng CM, Hsu JW, Huang KL, Bai YM. Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study. J Affect Disord. 2015;178:60\u20135.","journal-title":"J Affect Disord"},{"key":"1576_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jaad.2019.05.086","volume":"88","author":"JP Okhovat","year":"2023","unstructured":"Okhovat JP, Marks DH, Manatis-Lornell A, Hagigeorges D. Association between alopecia areata, anxiety, and depression: a systematic review and meta-analysis. J Am Acad Dermatol. 2023;88:1040\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"1576_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00403-021-02247-6","volume":"314","author":"D Tzur Bitan","year":"2022","unstructured":"Tzur Bitan D, Berzin D, Kridin K, Cohen A. The association between alopecia areata and anxiety, depression, schizophrenia, and bipolar disorder: a population-based study. Arch Dermatol Res. 2022;314:463\u20138.","journal-title":"Arch Dermatol Res"},{"key":"1576_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/bjd.21055","volume":"187","author":"AE Macbeth","year":"2022","unstructured":"Macbeth AE, Holmes S, Harries M, Chiu WS. The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care. Br J Dermatol. 2022;187:73\u201381.","journal-title":"Br J Dermatol"},{"key":"1576_CR22","doi-asserted-by":"crossref","unstructured":"Krajewski PK, Z\u0142otowska A, Szepietowski JC, Saceda Corralo D. Sexual dysfunction in alopecia areata: a systematic review. J Clin Med. 2025;14","DOI":"10.3390\/jcm14082602"},{"key":"1576_CR23","first-page":"397","volume":"8","author":"AC Villasante Fricke","year":"2015","unstructured":"Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397\u2013403.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1576_CR24","doi-asserted-by":"crossref","unstructured":"Seo HM, Kim TL, Kim JS. The risk of alopecia areata and other related autoimmune diseases in patients with sleep disorders: a Korean population-based retrospective cohort study. Sleep. 2018;41.","DOI":"10.1093\/sleep\/zsy111"},{"key":"1576_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192013126","author":"M S\u00e1nchez-D\u00edaz","year":"2022","unstructured":"S\u00e1nchez-D\u00edaz M, D\u00edaz-Calvillo P, Soto-Moreno A, Molina-Leyva A. The impact of sleep quality on mood status and quality of life in patients with alopecia areata: a comparative study. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph192013126.","journal-title":"Int J Environ Res Public Health"},{"key":"1576_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.576","volume":"5","author":"S Shakoei","year":"2022","unstructured":"Shakoei S, Torabimirzaee A, Saffarian Z, Abedini R. Sleep disturbance in alopecia areata: a cross-sectional study. Health Sci Rep. 2022;5:e576.","journal-title":"Health Sci Rep"},{"key":"1576_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1159\/000539424","volume":"10","author":"KL Curtis","year":"2024","unstructured":"Curtis KL, Stubblefield O, Lipner SR. Alopecia areata is associated with posttraumatic stress disorder and alcohol use in a case-control study of 4785 patients. Skin Appendage Disord. 2024;10:520\u20133.","journal-title":"Skin Appendage Disord"},{"key":"1576_CR28","first-page":"138","volume":"158","author":"B Kirby","year":"2008","unstructured":"Kirby B, Richards HL, Mason DL, Fortune DG. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol. 2008;158:138\u201340.","journal-title":"Br J Dermatol"},{"key":"1576_CR29","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1159\/000530076","volume":"239","author":"LH Wang","year":"2023","unstructured":"Wang LH, Ma SH, Tai YH, Dai YX. Increased risk of suicide attempt in patients with alopecia areata: a nationwide population-based cohort study. Dermatology. 2023;239:712\u20139.","journal-title":"Dermatology"},{"key":"1576_CR30","doi-asserted-by":"crossref","unstructured":"Hrvatin Stancic B, Henning MAS, Eriksen N, Emilie Dornonville de la Cour J. Completed suicide in patients with skin disease: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2025","DOI":"10.1111\/jdv.20609"},{"key":"1576_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2020.110347","volume":"141","author":"M Pompili","year":"2021","unstructured":"Pompili M, Bonanni L, Gualtieri F, Trovini G. Suicidal risks with psoriasis and atopic dermatitis: systematic review and meta-analysis. J Psychosom Res. 2021;141:110347.","journal-title":"J Psychosom Res"},{"key":"1576_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","volume":"138","author":"L Thorlacius","year":"2018","unstructured":"Thorlacius L, Cohen AD, Gislason GH, Jemec GBE. Increased suicide risk in patients with hidradenitis suppurativa. J Invest Dermatol. 2018;138:52\u20137.","journal-title":"J Invest Dermatol"},{"key":"1576_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bbi.2020.05.048","volume":"89","author":"N Vindegaard","year":"2020","unstructured":"Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun. 2020;89:531\u201342.","journal-title":"Brain Behav Immun"},{"key":"1576_CR34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00787-021-01856-w","volume":"32","author":"U Panchal","year":"2023","unstructured":"Panchal U, Salazar de Pablo G, Franco M, Moreno C. The impact of COVID-19 lockdown on child and adolescent mental health: systematic review. Eur Child Adolesc Psychiatry. 2023;32:1151\u201377.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1576_CR35","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jad.2021.08.067","volume":"295","author":"Y Jin","year":"2021","unstructured":"Jin Y, Sun T, Zheng P, An J. Mass quarantine and mental health during COVID-19: a meta-analysis. J Affect Disord. 2021;295:1335\u201346.","journal-title":"J Affect Disord"},{"key":"1576_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031038","author":"Y Minokawa","year":"2022","unstructured":"Minokawa Y, Sawada Y, Nakamura M. Lifestyle factors involved in the pathogenesis of alopecia areata. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031038.","journal-title":"Int J Mol Sci"},{"key":"1576_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jdin.2022.02.002","volume":"7","author":"RE Christensen","year":"2022","unstructured":"Christensen RE, Jafferany M. Association between alopecia areata and COVID-19: a systematic review. JAAD Int. 2022;7:57\u201361.","journal-title":"JAAD Int"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01576-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:40:33Z","timestamp":1770190833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01576-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1576"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01576-y","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ralf J. Ludwig has received financial support for travel from TriNetX. David Saceda Corralo is an Editorial Board member of\u00a0\n                      Dermatology and Therapy\n                      . David Saceda Corralo was not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions. Jacek C. Szepietowski is an Editorial Board member of\u00a0\n                      Dermatology and Therapy\n                      . Jacek C. Szepietowski was not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions. Katarzyna \u0141uczak, Aleksandra S\u00f3jka, and Piotr K. Krajewski have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This study utilized deidentified electronic health records. All patient data in the TriNetX database are certified as anonymized under Section \u00a7164.514(a) and \u00a7164.514(b)(1) of the HIPAA Privacy Rule and, when relevant, the GDPR of the European Union. No individual informed consent was needed because of the fully de-identified data. All analyses adhered to applicable data protection and privacy laws at both national and international levels. Access to TriNetX was granted through data use agreements and ethical standards maintained at each participating site.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}